Metraipolis › archive › dc_797dd67c183d

The use of Eculizumab and Tocilizumab in the treatment of Hyperhemolysis syndrome, a comprehensive literature review — Europe PMC PMID:41035870

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41035870
DOI: 10.3389/fmed.2025.1651895
License (as archived): solo-consultazione
Archived: 2026-11-09T22:46:43.823Z
SHA-256 of the archived text: 36e50ddac708ee48dcffb0e3ee4dfb16164bfac3f8c6c89345465f417074d0b1
Stable URL of this page: https://metraipolis.com/documento/dc_797dd67c183d

How to cite

The use of Eculizumab and Tocilizumab in the treatment of Hyperhemolysis syndrome, a comprehensive literature review — Europe PMC PMID:41035870 — Europe PMC (en), https://europepmc.org/article/MED/41035870 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_797dd67c183d (Metraipolis archive dc_797dd67c183d, sha256 36e50ddac708ee48dcffb0e3ee4dfb16164bfac3f8c6c89345465f417074d0b1)

BibTeX

@misc{dc797dd67c183d,
  title = {The use of Eculizumab and Tocilizumab in the treatment of Hyperhemolysis syndrome, a comprehensive literature review — Europe PMC PMID:41035870},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41035870},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_797dd67c183d; sha256 36e50ddac708ee48dcffb0e3ee4dfb16164bfac3f8c6c89345465f417074d0b1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41035870. Agents can read the archived copy with the MCP tool read_document.